The importance of public engagement in clinical xenotransplantation

Daniel J Hurst1, David K C Cooper2

  • 1Department of Family Medicine Rowan-Virtua School of Osteopathic Medicine Stratford New Jersey USA.

Health Care Science
|June 28, 2024
PubMed

Insights

Public engagement is crucial for advancing xenotransplantation, including pig organ transplants. Further research is needed to understand public views and address concerns for successful clinical integration.

Area of Science:

  • Transplantation Biology
  • Bioethics
  • Public Health

Background:

  • Significant scientific advancements in xenotransplantation have positioned the field for clinical trials.
  • Recent experimental pig kidney and heart xenotransplantation in human decedents and living patients highlight the field's progress.
  • Despite progress, public perception, concerns, and engagement strategies for xenotransplantation remain underexplored.

Purpose of the Study:

  • To emphasize the critical need for public engagement in xenotransplantation.
  • To review existing evidence on public engagement studies and identify knowledge gaps.
  • To propose actionable steps for advancing public engagement in xenotransplantation research.

Main Methods:

  • Review of current evidence on public engagement studies in xenotransplantation.
  • Identification of gaps in understanding public attitudes and concerns.
  • Proposal of practical steps and recommendations for future research.

Main Results:

  • Existing research on public engagement in xenotransplantation is limited, with significant gaps in understanding.
  • There is a need for studies examining racial/ethnic differences in attitudes towards xenotransplantation.
  • Analysis of religious viewpoints, particularly minority faiths, is valuable for comprehensive understanding.

Conclusions:

  • Public engagement is essential for the acceptance and ethical implementation of xenotransplantation.
  • Further research is required to address specific demographic and cultural perspectives on xenotransplantation.
  • Biotechnology companies should consider funding public engagement research to foster trust and acceptance.